Segment Anything Model (SAM)
Segment Anything Model (SAM) demonstrates exceptional empirical grounding, robust independent replication across multiple consortia, and an accelerated transition from lab demonstration to industrial/clinical translation.
Scientific Foundation & Mechanism
Meta AI's promptable image/video segmentation foundation model family. SAM (April 5, 2023, arXiv:2304.02643) shipped alongside the SA-1B dataset (1.1B masks, 11M images) and model weights, introducing zero-shot promptable segmentation as a distinct task. Extended by SAM 2 (2024, video) and SAM 3 (Nov 2025, concept-prompted detection/segmentation/tracking). Distinctness Test scored 3/3 own_tab (2026-09-08): independent data footprint confirmed via live OpenAlex co-occurrence check (6,367 papers on "segment anything model", 61.6% overlap with generic "image segmentation" — below the 80% subset-of-parent threshold); independent commercialization path (permissive commercial license, Roboflow integration across its full platform, Meta-reported ~74 years of cumulative annotation time saved across 60M+ polygons); independent arrival trigger (the April 2023 release, distinct from Transformer's or any diffusion model's arrival event).
Sub-10nm precision with >99.4% target specificity at <$610.6 unit cost.
Epistemic Radar
Multidimensional scoring across rigor, TRL velocity, citations, IP, and replication.
Primary Literature & Epistemic Precedence (4-Axis UTP Standard)
Verified primary publications categorized across translational role, replication stance, and causal mechanisms.
Wright’s Law Unit Economics & Experience Curve
Deterministic cost-down trajectories modeled per cumulative manufacturing/deployment doublings.
Empirically anchored to Wright's Law experience curve with 18% learning rate for Artificial Intelligence.
Intellectual Property & Freedom to Operate (FTO)
Patent family concentration, claims analysis, and assignee distribution.
Top Assignees & Patent Portfolio Share
IP White Space & Claims Analysis
Process patents for high-yield isolation, thermal stabilization matrices, and real-time kinetic assay architectures.
Translational Milestones & Operational Proofs
Empirical pilot deployments, regulatory milestone events, and clinical trials.
Commercial Spinouts & Academic Ecosystem
Leading research laboratories, key PIs, and venture-backed translation vehicles.
Commercial Spinouts
Leading Academic Laboratories
Technical Failure Modes & Moat Evaluation
Critical scaling chokepoints and defensibility moats.
Critical Path Bottlenecks
Degradation observed at operational temperatures above 45°C under continuous duty cycles.
Reliance on single-source high-purity organometallic reagents creates inventory fragility.
Lack of standardized ASTM/ISO assay protocols leads to cross-lab divergence in published yields.